About
Histosonics

Origin of histotripsy

A walking path on The University of Michigan
The science of histotripsy was developed by leading ultrasound scientists from the University of Michigan as a non-invasive potential alternative to certain surgical procedures.

Translating science to clinical practice

Leading multi-disciplinary clinicians from the University of Wisconsin and the University of Michigan collaborate through ongoing partnerships with HistoSonics to bring histotripsy into everyday clinical practice.
Medical screen

Executive Team

Male professional headshot

Mike Blue

President, CEO, Board Member
Male professional headshot

Josh Stopek, PhD

Chief Technology Officer
Male professional headshot

David Krenn

Chief Financial Officer
Male professional headshot

Donald Hayden

VP of Global Sales and Marketing
Male professional headshot

Amanda Cafaro

VP of Clinical Affairs
Male professional headshot

Joe Herman, MD

VP of Medical Affairs
Male professional headshot

Michele Bossert

VP of Society Engagement
Male professional headshot

Dan Kosednar

VP of Regulatory Affairs
Male professional headshot

Josh King

VP of Strategic Initiatives
Male professional headshot

Barbara Peterson

VP of Reimbursement
Male professional headshot

Eric Clyse

VP of Operations
Male professional headshot

Steve Augustine

VP of Human Resources

Ready to learn more about us?
Connect with the HistoSonics team.

Contact Us

Last updated on March 31, 2025

Caution: Federal law (USA) restricts this device to sale by or on the order of a physician.

The is intended for the non-invasive mechanical destruction of liver tumors, including the partial or complete destruction of unresectable liver tumors via histotripsy. The FDA has not evaluated the for the treatment of any disease including, but not limited to, cancer or evaluated any specific cancer outcomes (such as local tumor progression, 5-year survival or overall survival). The System should only be used by persons who have completed training performed by HistoSonics Inc., and its use guided by the clinical judgment of an appropriately trained physician. Refer to the device Instructions for Use for a complete list of warnings, precautions and a summary of clinical trial results, including reported adverse events.

Footer last updated on June 30, 2025
X New Twitter Logo
© 2019-2025 HistoSonics®. All rights reserved.
HistoSonics
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.